Clinical Trial Update: Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors [Phase 2]

View source ↗

Summary

Phase 2 feasibility study evaluating pazopanib in combination with chemotherapy for gynecologic tumors; the trial has completed and results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Primary Peritoneal Carcinoma, Tumor | Phase 2 | Status: COMPLETED | Results posted: 2010-12-07